SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-101257
Filing Date
2016-05-12
Accepted
2016-05-12 16:08:04
Documents
55
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v439186_10q.htm 10-Q 296850
2 EXHIBIT 31.1 v439186_ex31-1.htm EX-31.1 9948
3 EXHIBIT 31.2 v439186_ex31-2.htm EX-31.2 9959
4 EXHIBIT 32.1 v439186_ex32-1.htm EX-32.1 5095
  Complete submission text file 0001144204-16-101257.txt   3334261

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT aktx-20160331.xml EX-101.INS 698862
6 XBRL TAXONOMY EXTENSION SCHEMA aktx-20160331.xsd EX-101.SCH 35234
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aktx-20160331_cal.xml EX-101.CAL 28779
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aktx-20160331_def.xml EX-101.DEF 234520
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aktx-20160331_lab.xml EX-101.LAB 262993
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aktx-20160331_pre.xml EX-101.PRE 271627
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 10-Q | Act: 34 | File No.: 001-36288 | Film No.: 161643769
SIC: 2834 Pharmaceutical Preparations